American Healthcare REIT (NYSE:AHR) Issues FY 2024 Earnings Guidance

American Healthcare REIT (NYSE:AHRGet Free Report) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided EPS guidance of 1.180-1.240 for the period, compared to the consensus EPS estimate of 1.220. The company issued revenue guidance of -.

American Healthcare REIT Trading Up 1.0 %

Shares of AHR traded up $0.14 during trading hours on Thursday, hitting $14.18. 890,369 shares of the stock were exchanged, compared to its average volume of 874,312. American Healthcare REIT has a 12-month low of $12.63 and a 12-month high of $14.56.

American Healthcare REIT Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, April 19th. Shareholders of record on Thursday, March 28th will be given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a yield of 7.05%. The ex-dividend date is Wednesday, March 27th.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on AHR shares. Bank of America began coverage on American Healthcare REIT in a research report on Monday, March 4th. They set a buy rating and a $15.00 price objective for the company. Morgan Stanley initiated coverage on American Healthcare REIT in a report on Monday, March 4th. They issued an overweight rating and a $17.00 price target for the company. JMP Securities initiated coverage on American Healthcare REIT in a research note on Monday, March 4th. They issued a mkt outperform rating and a $16.00 target price for the company. KeyCorp initiated coverage on American Healthcare REIT in a research report on Monday, March 4th. They issued an overweight rating and a $16.00 target price for the company. Finally, Citigroup initiated coverage on American Healthcare REIT in a research report on Monday, March 4th. They issued a neutral rating and a $14.00 target price for the company. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of Moderate Buy and an average price target of $16.00.

Read Our Latest Research Report on AHR

Insider Activity

In other news, Director Mathieu B. Streiff bought 83,333 shares of the company’s stock in a transaction that occurred on Friday, February 9th. The shares were acquired at an average price of $12.00 per share, with a total value of $999,996.00. Following the transaction, the director now owns 90,740 shares in the company, valued at $1,088,880. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

About American Healthcare REIT

(Get Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Read More

Earnings History and Estimates for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.